Group B streptococcus vaccination in pregnant women with or without HIV in Africa: a non-randomised phase 2, open-label, multicentre trial-Reference-Cited by-同舟云学术

Group B streptococcus vaccination in pregnant women with or without HIV in Africa: a non-randomised phase 2, open-label, multicentre trial

Published:2016-05 Issue:5 Volume:16 Page:546-555
ISSN:1473-3099
Container-title:The Lancet Infectious Diseases
language:en
Short-container-title:The Lancet Infectious Diseases

Author:

Heyderman Robert S,Madhi Shabir A,French Neil,Cutland Clare,Ngwira Bagrey,Kayambo Doris,Mboizi Robert,Koen Anthonet,Jose Lisa,Olugbosi Morounfolu,Wittke Frederik,Slobod Karen,Dull Peter M

Publisher

Elsevier BV

Subject

Infectious Diseases

Reference30 articles.

1. Global, regional, and national causes of child mortality in 2000–13, with projections to inform post-2015 priorities: an updated systematic analysis;Liu;Lancet,2015

2. Variation in reported neonatal group B streptococcal disease incidence in developing countries;Dagnew;Clin Infect Dis,2012

3. Early onset neonatal sepsis: the burden of group B Streptococcal and E. coli disease continues;Stoll;Pediatrics,2011

4. Group B streptococcus late-onset disease: 2003–2010;Berardi;Pediatrics,2013

5. Maternal immunization with Haemophilus influenzae type b vaccines in different populations;Englund;Vaccine,2003

Cited by 108 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prevention of fetal and early life infections through maternal-neonatal immunization;Remington and Klein's Infectious Diseases of the Fetus and Newborn Infant;2025

3. The safety and immunogenicity of vaccines administered to pregnant women living with HIV: a systematic review and meta-analysis;eClinicalMedicine;2024-03

4. “Why has this new vaccine come and for what reasons?” key antecedents and questions for acceptance of a future maternal GBS vaccine: Perspectives of pregnant women, lactating women, and community members in Kenya;Human Vaccines & Immunotherapeutics;2024-02-12

5. Obstetric and neonatal outcomes in South Africa;Vaccine;2024-02